It
has been a while since we have sent any updates for our dietary supplement
clients. The FDA has remained busy inspecting supplement companies and
writing many, many warning letters. The regulations for dietary supplement Good
Manufacturing Practices (GMPs) include a section on quality control
requirements (21 CFR 111.103 – 111.40). Many dietary supplement
distributors mistakenly think that quality control is the responsibility of
their contract manufacturers. There have been a number of warning letters
to companies who failed to have sufficient oversight or documentation of the
system in place to ensure that their contract manufacturer was producing the
product specified. A recent letter to Body Systems, Inc. of Winter
Springs, FL delineates this responsibility and in addition states that failure to fulfill
this responsibility can result I criminal liability:
“Although your firm may contract out certain
dietary supplement manufacturing operations, it cannot, by the same token,
contract out its ultimate responsibility to ensure that the dietary supplement
it places into commerce (or causes to be placed into commerce) is not
adulterated for failure to comply with dietary supplement CGMP requirements
(see United States v. Dotterweich, 320 U.S. 277, 284 (1943) (explaining that an
offense can be committed under the Act by anyone who has “a responsible share
in the furtherance of the transaction which the statute outlaws”); United
States v. Park, 421 U.S. 658, 672 (1975) (holding that criminal liability under
the Act does not turn on awareness of wrongdoing, and that “agents vested with
the responsibility, and power commensurate with that responsibility, to devise
whatever measures are necessary to ensure compliance with the Act” can be held
accountable for violations of the Act). In particular, the Act prohibits a
person from introducing or delivering for introduction, or causing the delivery
or introduction, into interstate commerce a dietary supplement that is
adulterated under section 402(g) for failure to comply with dietary supplement
CGMP requirements (see 21 U.S.C. §§ 342(g) and 331(a)). Thus, a firm that
contracts with other firms to conduct certain dietary supplement manufacturing,
packaging, and labeling operations for it is responsible for ensuring that the
product is not adulterated for failure to comply with dietary supplement CGMP
requirements, regardless of who actually performs the dietary supplement CGMP
operations.”
An
initial step for dietary supplement companies to take in order to address their
responsibilities is to carefully write the contracts and agreements they have
with their contract manufacturers. This week FDA issued a draft guidance
document on quality agreements for the drug industry. While reading through it,
I thought that many of the suggestions are relevant to the dietary supplement
industry. The draft guidance discusses how both the ‘Owner’ of the
product and the contract manufacturing facility are responsible for quality
control and compliance with GMP regulations. The same is true in dietary
supplement manufacturing. In the following excerpt from the draft
guidance on quality agreements, think “dietary supplement” when you read
“drug.” (Note that I have separated theses sentences for emphasis but they
appear in a single paragraph in FDA’s document.)
“In all cases, the Owner is responsible for
assuring that drugs introduced for interstate commerce are neither adulterated
nor misbranded as a result of the actions of their selected Contracted
Facilities.
All Contracted Facilities must assure
compliance with applicable Current Good Manufacturing Practices for all
manufacturing, testing or other support operations performed to make a drug(s)
for the Owner.”
The
second sentence states that the contract manufacturer must assure compliance
with GMPs. While first sentence states that the company that will introduce the
product into commerce, the “Owner” must take steps to ensure that the product
has been properly manufactured. This requires auditing of the
manufacturing process by the Owner to ensure that the manufacturer is
fulfilling the contract. It may be helpful to read the full
guidance here. At the very least, it can provide things to think about as you
work with your contract manufacturer.
My
associates and I hope you find these occasional updates helpful. If you would like to subscribe to our newsletter updates on foods, cosmetics, dietary supplements or over the counter drugs, simply reply to this post and let us know.
Contact
us if you have questions or need help ensuring that your company is in compliance
with FDA regulations.
Sincerely,
Evelyn
& Associates
No comments:
Post a Comment